Flu shot for flu season, HHS gender report: Morning Rounds

2 3 minutes read

Stay informed about the latest in health and medicine with STAT’s Morning Rounds newsletter, delivered to your inbox every weekday. Sign up here.

Good day. I’d like to express my gratitude to Rose Broderick for stepping in to cover the first item in today’s newsletter while I delved into another story. Keep reading to discover the topic I’ve been investigating.

Rising Health Insurance Premiums

The tax credits that helped Americans purchase health insurance plans through the Affordable Care Act’s marketplaces during the pandemic are scheduled to expire at the end of the year. With no apparent intervention from politicians on the horizon, insurance premiums could potentially double next year.

Who will be impacted by this change? Individuals who have health insurance through the marketplace and earn approximately four times the federal poverty level. While the original premium tax credits provided by the Affordable Care Act will remain intact, the additional credits extended by Democrats during the pandemic are likely to be discontinued. This is due to the fact that 13 Republicans would need to vote in favor of an extension, but agreement on the matter seems elusive.

For more in-depth insights into the repercussions, refer to STAT’s coverage by John Wilkerson.

Pfizer’s Experimental Flu Shot & an Intense Flu Season?

Pfizer recently reported enhanced effectiveness of its experimental mRNA-based flu shot against influenza A viruses in a Phase 3 trial published in the New England Journal of Medicine. Adults aged 18 to 64 who received Pfizer’s modified mRNA shot exhibited better protection against flu A compared to those who received Sanofi’s Fluzone shot. The trial did not have substantial flu B activity during the study period, making it challenging to estimate vaccine efficacy against those viruses.

An editorial accompanying the results highlighted the less impressive outcomes of testing the vaccine in adults aged 65 and older, a crucial demographic for flu vaccination. These results were not included in the current publication.

As medical professionals brace for a potentially severe flu season, concerns arise over mutated H3N2 viruses, a flu A subtype that could evade vaccine-induced antibodies. The emergence of a new variant, subclade K, further complicates matters as traditional flu shots were unable to target these viruses in the current season. Researchers like Scott Hensley advocate for mRNA flu shots due to their shorter production timeline compared to traditional methods. Despite the mutation, experts advise against skipping the flu shot this year, emphasizing the importance of vaccination.

HHS Revises Gender Dysphoria Report

Yesterday, the Department of Health and Human Services (HHS) reissued its contentious report on gender dysphoria in children, now disclosing the identities of the previously anonymous authors and sharing select peer-review comments. Critics of gender-affirming care anticipate that the updated report will support forthcoming proposed regulations from the Centers for Medicare and Medicaid Services, aiming to restrict federal funding for such care for minors and healthcare facilities providing it.

The revised report sheds light on the affiliations of many authors and reviewers, revealing their opposition to gender-affirming care and limited clinical experience with young transgender individuals. Some have financial ties to anti-LGBTQ+ groups and have actively spoken against treating children with gender-affirming interventions. For a comprehensive analysis of the contributors, delve into the coverage by myself and Annalisa Merelli.

Exploring RFK Jr.’s Tenure at HHS

Robert F. Kennedy Jr. embodies a unique blend of contradictions as a member of the Kennedy family serving in a conservative Republican administration. With a keen interest in health, Kennedy’s advocacy for raw milk consumption and vaccine skepticism have stirred controversy.

In this week’s STATus Report, host Alex Hogan delves into the complexities of RFK Jr. with STAT Washington correspondent Chelsea Cirruzzo. A recent STAT investigation conducted with reporters Casey Ross and Sarah Todd delves into Kennedy’s impact on federal health agencies during his tenure as health secretary. Watch the insightful video detailing the investigation.

Reevaluating Longevity: Quantity vs. Quality

Silicon Valley’s fixation on “defeating death” has spurred substantial investments in longevity technologies, regenerative medicine, and various health interventions. Biohackers engage in fasting, cold therapy, and experimental treatments to extend lifespan by leveraging cutting-edge advancements in healthcare.

Anthropologist Michael Gurven presents a thought-provoking perspective in a recent First Opinion essay, questioning the focus on extending life at the expense of enhancing its quality. Gurven advocates for prioritizing interventions that address preventable causes of mortality, emphasizing the significance of maximizing the quality of life rather than merely extending its duration. Explore Gurven’s recommendations for a more holistic approach to longevity.